OWKIN Company Culture
OWKIN Culture
This score is derived from employee ratings & reviewsTop Rated Culture Dimensions
Share Your Opinion
Anonymously Rate Your Experience & Make Work BetterOWKIN Company Information
OWKIN Company Overview
Analyzing patient data of today to find treatments of tomorrow
| Headquarter | New York United States of America |
|---|---|
| Founding Date | 2016 |
| Company Status | Private |
OWKIN Competitors
OWKIN competitors include MPI Research and Acceleron Pharma. OWKIN ranks 2nd in Overall Culture Score on Comparably vs its competitors. See below how OWKIN compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.
OWKIN Employees
2 employees at OWKIN have reviewed OWKIN across various culture dimensions, providing their opinions on items ranging from executive ratings to the pace at work. The latest review was months ago.
Joining OWKIN - Employee Onboarding
The prevailing opinion from Comparably users about their company is that it was very prepared on their first day. Employees concluded that their overall onboarding experience was positive. 73% said their direct manager was helpful with their acclimation during the first 90 days. First impressions are important, and how prepared a company is on your first day leaves a lasting impression.
OWKIN KPIs and OKRs
At this moment no OWKIN employees have provided insight into whether or not they clearly understand OWKIN's KPIs and OKRs.
Are your company's goals clear, and are you invested in them?
Are the KPIs/OKRs for your department clear?
OWKIN Careers
OWKIN Jobs
No Recent Jobs found for OWKIN on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably
Let OWKIN Know You Want To Work There
Frequently Asked Questions regarding OWKIN
What is OWKIN address?
OWKIN location is at New York
What is OWKIN eNPS?
The eNPS for OWKIN is 100
Who are OWKIN competitors?
OWKIN main competitors are MPI Research, Acceleron Pharma
×